Trichovirin II 2c
| Internal ID | 64e7f5cc-4098-45fa-8d5d-acddc0ee0099 |
| Taxonomy | Organic Polymers > Polypeptides |
| IUPAC Name | 2-[[2-[[2-[[2-[[1-[2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-[2-[[2-[(2-acetamido-2-methylpropanoyl)amino]acetyl]amino]propanoylamino]-4-methylpentanoyl]amino]-2-methylpropanoyl]amino]-5-amino-5-oxopentanoyl]amino]-3-methylbutanoyl]amino]-3-methylbutanoyl]amino]-2-methylpropanoyl]amino]acetyl]amino]-2-methylpropanoyl]amino]-2-methylpropanoyl]pyrrolidine-2-carbonyl]amino]-4-methylpentanoyl]amino]-2-methylpropanoyl]amino]-2-methylpropanoyl]amino]-N-(1-hydroxy-4-methylpentan-2-yl)pentanediamide |
| SMILES (Canonical) | |
| SMILES (Isomeric) | |
| InChI | InChI=1S/C80H140N20O21/c1-40(2)34-47(39-101)86-60(108)48(29-31-53(81)103)89-70(118)77(19,20)98-72(120)79(23,24)96-63(111)51(36-42(5)6)88-64(112)52-28-27-33-100(52)73(121)80(25,26)99-71(119)78(21,22)94-56(106)38-84-68(116)75(15,16)97-66(114)58(44(9)10)92-65(113)57(43(7)8)91-61(109)49(30-32-54(82)104)90-69(117)76(17,18)95-62(110)50(35-41(3)4)87-59(107)45(11)85-55(105)37-83-67(115)74(13,14)93-46(12)102/h40-45,47-52,57-58,101H,27-39H2,1-26H3,(H2,81,103)(H2,82,104)(H,83,115)(H,84,116)(H,85,105)(H,86,108)(H,87,107)(H,88,112)(H,89,118)(H,90,117)(H,91,109)(H,92,113)(H,93,102)(H,94,106)(H,95,110)(H,96,111)(H,97,114)(H,98,120)(H,99,119) |
| InChI Key | GDPJIKURNIWHSE-UHFFFAOYSA-N |
| Popularity | 2 references in papers |
| Molecular Formula | C80H140N20O21 |
| Molecular Weight | 1718.10 g/mol |
| Exact Mass | 1717.05019156 g/mol |
| Topological Polar Surface Area (TPSA) | 621.00 Ų |
| XlogP | -0.60 |
| Atomic LogP (AlogP) | -3.63 |
| H-Bond Acceptor | 21 |
| H-Bond Donor | 20 |
| Rotatable Bonds | 49 |
| RefChem:191328 |
| 2-((1-hydroxy-2-((1-hydroxy-2-((1-hydroxy-2-((1-hydroxy-2-((1-hydroxy-2-((1-hydroxyethylidene)amino)-2-methylpropylidene)amino)ethylidene)amino)propylidene)amino)-4-methylpentylidene)amino)-2-methylpropylidene)amino)-N-(1-((1-((1-((((1-((1-(2-((1-((1-((1-((1-((1-hydroxy-4-methylpentan-2-yl)-C-hydroxycarbonimidoyl)-3-(C-hydroxycarbonimidoyl)propyl)-C-hydroxycarbonimidoyl)-1-methylethyl)-C-hydroxycarbonimidoyl)-1-methylethyl)-C-hydroxycarbonimidoyl)-3-methylbutyl)-C-hydroxycarbonimidoyl)pyrrolidin-1-yl)-2-methyl-1-oxopropan-2-yl)-C-hydroxycarbonimidoyl)-1-methylethyl)-C-hydroxycarbonimidoyl)methyl)-C-hydroxycarbonimidoyl)-1-methylethyl)-C-hydroxycarbonimidoyl)-2-methylpropyl)-C-hydroxycarbonimidoyl)-2-methylpropyl)pentanediimidate |
| 2-((2-((2-((2-((1-(2-((2-((2-((2-((2-((2-((2-((2-((2-(2-((2-((2-acetamido-2-methylpropanoyl)amino)acetyl)amino)propanoylamino)-4-methylpentanoyl)amino)-2-methylpropanoyl)amino)-5-amino-5-oxopentanoyl)amino)-3-methylbutanoyl)amino)-3-methylbutanoyl)amino)-2-methylpropanoyl)amino)acetyl)amino)-2-methylpropanoyl)amino)-2-methylpropanoyl)pyrrolidine-2-carbonyl)amino)-4-methylpentanoyl)amino)-2-methylpropanoyl)amino)-2-methylpropanoyl)amino)-N-(1-hydroxy-4-methylpentan-2-yl)pentanediamide |
| 2-[[2-[[2-[[2-[[1-[2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-[[2-[2-[[2-[(2-acetamido-2-methylpropanoyl)amino]acetyl]amino]propanoylamino]-4-methylpentanoyl]amino]-2-methylpropanoyl]amino]-5-amino-5-oxopentanoyl]amino]-3-methylbutanoyl]amino]-3-methylbutanoyl]amino]-2-methylpropanoyl]amino]acetyl]amino]-2-methylpropanoyl]amino]-2-methylpropanoyl]pyrrolidine-2-carbonyl]amino]-4-methylpentanoyl]amino]-2-methylpropanoyl]amino]-2-methylpropanoyl]amino]-N-(1-hydroxy-4-methylpentan-2-yl)pentanediamide |
| 2-{[1-hydroxy-2-({1-hydroxy-2-[(1-hydroxy-2-{[1-hydroxy-2-({1-hydroxy-2-[(1-hydroxyethylidene)amino]-2-methylpropylidene}amino)ethylidene]amino}propylidene)amino]-4-methylpentylidene}amino)-2-methylpropylidene]amino}-N-(1-{[1-({1-[({[1-({1-[2-({1-[(1-{[1-({1-[(1-hydroxy-4-methylpentan-2-yl)-C-hydroxycarbonimidoyl]-3-(C-hydroxycarbonimidoyl)propyl}-C-hydroxycarbonimidoyl)-1-methylethyl]-C-hydroxycarbonimidoyl}-1-methylethyl)-C-hydroxycarbonimidoyl]-3-methylbutyl}-C-hydroxycarbonimidoyl)pyrrolidin-1-yl]-2-methyl-1-oxopropan-2-yl}-C-hydroxycarbonimidoyl)-1-methylethyl]-C-hydroxycarbonimidoyl}methyl)-C-hydroxycarbonimidoyl]-1-methylethyl}-C-hydroxycarbonimidoyl)-2-methylpropyl]-C-hydroxycarbonimidoyl}-2-methylpropyl)pentanediimidate |
| CHEBI:220629 |
| Target | Value | Probability (raw) | Probability (%) |
|---|---|---|---|
| Human Intestinal Absorption | + | 0.6378 | 63.78% |
| Caco-2 | - | 0.8584 | 85.84% |
| Blood Brain Barrier | - | 0.6250 | 62.50% |
| Human oral bioavailability | - | 0.6143 | 61.43% |
| Subcellular localzation | Lysosomes | 0.6336 | 63.36% |
| OATP2B1 inhibitior | - | 1.0000 | 100.00% |
| OATP1B1 inhibitior | + | 0.8537 | 85.37% |
| OATP1B3 inhibitior | + | 0.9436 | 94.36% |
| MATE1 inhibitior | - | 0.9412 | 94.12% |
| OCT2 inhibitior | - | 0.9250 | 92.50% |
| BSEP inhibitior | + | 0.9461 | 94.61% |
| P-glycoprotein inhibitior | + | 0.7422 | 74.22% |
| P-glycoprotein substrate | + | 0.8731 | 87.31% |
| CYP3A4 substrate | + | 0.7354 | 73.54% |
| CYP2C9 substrate | - | 0.7929 | 79.29% |
| CYP2D6 substrate | - | 0.8494 | 84.94% |
| CYP3A4 inhibition | - | 0.6691 | 66.91% |
| CYP2C9 inhibition | - | 0.9104 | 91.04% |
| CYP2C19 inhibition | - | 0.7736 | 77.36% |
| CYP2D6 inhibition | - | 0.8968 | 89.68% |
| CYP1A2 inhibition | - | 0.9082 | 90.82% |
| CYP2C8 inhibition | + | 0.6031 | 60.31% |
| CYP inhibitory promiscuity | - | 0.9753 | 97.53% |
| UGT catelyzed | + | 0.7000 | 70.00% |
| Carcinogenicity (binary) | - | 0.8300 | 83.00% |
| Carcinogenicity (trinary) | Non-required | 0.6153 | 61.53% |
| Eye corrosion | - | 0.9784 | 97.84% |
| Eye irritation | - | 0.8955 | 89.55% |
| Skin irritation | - | 0.7825 | 78.25% |
| Skin corrosion | - | 0.8833 | 88.33% |
| Ames mutagenesis | - | 0.6878 | 68.78% |
| Human Ether-a-go-go-Related Gene inhibition | + | 0.7018 | 70.18% |
| Micronuclear | + | 0.5700 | 57.00% |
| Hepatotoxicity | - | 0.5218 | 52.18% |
| skin sensitisation | - | 0.8840 | 88.40% |
| Respiratory toxicity | + | 0.8000 | 80.00% |
| Reproductive toxicity | + | 0.8000 | 80.00% |
| Mitochondrial toxicity | + | 0.6375 | 63.75% |
| Nephrotoxicity | - | 0.5962 | 59.62% |
| Acute Oral Toxicity (c) | III | 0.6620 | 66.20% |
| Estrogen receptor binding | - | 0.5180 | 51.80% |
| Androgen receptor binding | + | 0.7482 | 74.82% |
| Thyroid receptor binding | + | 0.7271 | 72.71% |
| Glucocorticoid receptor binding | + | 0.8131 | 81.31% |
| Aromatase binding | + | 0.7945 | 79.45% |
| PPAR gamma | + | 0.8002 | 80.02% |
| Honey bee toxicity | - | 0.7632 | 76.32% |
| Biodegradation | - | 0.9000 | 90.00% |
| Crustacea aquatic toxicity | + | 0.5024 | 50.24% |
| Fish aquatic toxicity | - | 0.7234 | 72.34% |
Proven Targets:
| CHEMBL ID | UniProt ID | Name | Min activity | Assay type | Source |
|---|---|---|---|---|---|
| No proven targets yet! | |||||
Predicted Targets (via Super-PRED):
| CHEMBL ID | UniProt ID | Name | Probability | Model accuracy |
|---|---|---|---|---|
| CHEMBL2581 | P07339 | Cathepsin D | 99.82% | 98.95% |
| CHEMBL3837 | P07711 | Cathepsin L | 99.71% | 96.61% |
| CHEMBL220 | P22303 | Acetylcholinesterase | 99.37% | 94.45% |
| CHEMBL4018 | P49146 | Neuropeptide Y receptor type 2 | 99.26% | 98.94% |
| CHEMBL1795139 | Q8IU80 | Transmembrane protease serine 6 | 98.96% | 98.33% |
| CHEMBL1914 | P06276 | Butyrylcholinesterase | 98.50% | 95.00% |
| CHEMBL2730 | P21980 | Protein-glutamine gamma-glutamyltransferase | 98.24% | 92.38% |
| CHEMBL236 | P41143 | Delta opioid receptor | 97.61% | 99.35% |
| CHEMBL4777 | P25929 | Neuropeptide Y receptor type 1 | 97.36% | 96.67% |
| CHEMBL3251 | P19838 | Nuclear factor NF-kappa-B p105 subunit | 97.27% | 96.09% |
| CHEMBL3359 | P21462 | Formyl peptide receptor 1 | 96.84% | 93.56% |
| CHEMBL253 | P34972 | Cannabinoid CB2 receptor | 96.83% | 97.25% |
| CHEMBL4625 | Q07817 | Apoptosis regulator Bcl-X | 96.70% | 99.77% |
| CHEMBL230 | P35354 | Cyclooxygenase-2 | 96.58% | 89.63% |
| CHEMBL2514 | O95665 | Neurotensin receptor 2 | 96.40% | 100.00% |
| CHEMBL4123 | P30989 | Neurotensin receptor 1 | 96.35% | 96.67% |
| CHEMBL237 | P41145 | Kappa opioid receptor | 96.22% | 98.10% |
| CHEMBL3137262 | O60341 | LSD1/CoREST complex | 96.17% | 97.09% |
| CHEMBL4394 | Q9NYA1 | Sphingosine kinase 1 | 96.05% | 96.03% |
| CHEMBL2094135 | Q96BI3 | Gamma-secretase | 95.97% | 98.05% |
| CHEMBL1907591 | P30926 | Neuronal acetylcholine receptor; alpha4/beta4 | 95.86% | 100.00% |
| CHEMBL259 | P32245 | Melanocortin receptor 4 | 95.84% | 95.38% |
| CHEMBL3176 | O43603 | Galanin receptor 2 | 95.54% | 98.89% |
| CHEMBL335 | P18031 | Protein-tyrosine phosphatase 1B | 95.47% | 95.17% |
| CHEMBL3437 | Q16853 | Amine oxidase, copper containing | 95.15% | 94.00% |
| CHEMBL3130 | O00329 | PI3-kinase p110-delta subunit | 94.74% | 96.47% |
| CHEMBL4588 | P22894 | Matrix metalloproteinase 8 | 94.73% | 94.66% |
| CHEMBL4816 | Q9Y243 | Serine/threonine-protein kinase AKT3 | 94.67% | 96.28% |
| CHEMBL340 | P08684 | Cytochrome P450 3A4 | 94.53% | 91.19% |
| CHEMBL4979 | P13866 | Sodium/glucose cotransporter 1 | 94.24% | 98.24% |
| CHEMBL2073 | P07947 | Tyrosine-protein kinase YES | 94.24% | 83.14% |
| CHEMBL3267 | P48736 | PI3-kinase p110-gamma subunit | 94.09% | 95.71% |
| CHEMBL5103 | Q969S8 | Histone deacetylase 10 | 93.97% | 90.08% |
| CHEMBL2693 | Q9UIQ6 | Cystinyl aminopeptidase | 93.68% | 97.64% |
| CHEMBL2815 | P04629 | Nerve growth factor receptor Trk-A | 93.24% | 87.16% |
| CHEMBL4227 | P25090 | Lipoxin A4 receptor | 93.09% | 100.00% |
| CHEMBL4478 | Q00975 | Voltage-gated N-type calcium channel alpha-1B subunit | 93.01% | 97.14% |
| CHEMBL2492 | P36544 | Neuronal acetylcholine receptor protein alpha-7 subunit | 92.78% | 88.42% |
| CHEMBL4026 | P40763 | Signal transducer and activator of transcription 3 | 92.36% | 82.69% |
| CHEMBL3024 | P53350 | Serine/threonine-protein kinase PLK1 | 92.33% | 97.43% |
| CHEMBL5619 | P27695 | DNA-(apurinic or apyrimidinic site) lyase | 92.31% | 91.11% |
| CHEMBL3830 | Q2M2I8 | Adaptor-associated kinase | 92.05% | 83.10% |
| CHEMBL2664 | P23526 | Adenosylhomocysteinase | 91.96% | 86.67% |
| CHEMBL1944495 | P28065 | Proteasome subunit beta type-9 | 91.87% | 97.50% |
| CHEMBL1907594 | P30926 | Neuronal acetylcholine receptor; alpha3/beta4 | 91.76% | 97.23% |
| CHEMBL4005 | P42336 | PI3-kinase p110-alpha subunit | 91.60% | 97.47% |
| CHEMBL2107 | P61073 | C-X-C chemokine receptor type 4 | 91.32% | 93.10% |
| CHEMBL3468 | P55210 | Caspase-7 | 90.87% | 95.68% |
| CHEMBL3018 | Q9Y5Y6 | Matriptase | 90.49% | 98.33% |
| CHEMBL4203 | Q9HAZ1 | Dual specificity protein kinase CLK4 | 90.45% | 94.45% |
| CHEMBL1873 | P00750 | Tissue-type plasminogen activator | 89.81% | 93.33% |
| CHEMBL4801 | P29466 | Caspase-1 | 89.44% | 96.85% |
| CHEMBL283 | P08254 | Matrix metalloproteinase 3 | 89.16% | 97.29% |
| CHEMBL333 | P08253 | Matrix metalloproteinase-2 | 88.98% | 96.31% |
| CHEMBL206 | P03372 | Estrogen receptor alpha | 88.24% | 97.64% |
| CHEMBL3807 | P17706 | T-cell protein-tyrosine phosphatase | 87.83% | 93.00% |
| CHEMBL2111367 | P27986 | PI3-kinase p110-alpha/p85-alpha | 87.71% | 94.33% |
| CHEMBL3892 | Q99500 | Sphingosine 1-phosphate receptor Edg-3 | 87.48% | 97.29% |
| CHEMBL5163 | Q9NY46 | Sodium channel protein type III alpha subunit | 87.47% | 96.90% |
| CHEMBL2274 | Q9H228 | Sphingosine 1-phosphate receptor Edg-8 | 87.41% | 100.00% |
| CHEMBL274 | P51681 | C-C chemokine receptor type 5 | 87.36% | 98.77% |
| CHEMBL2534 | O15530 | 3-phosphoinositide dependent protein kinase-1 | 86.62% | 95.36% |
| CHEMBL1841 | P06241 | Tyrosine-protein kinase FYN | 86.57% | 81.29% |
| CHEMBL1075094 | Q16236 | Nuclear factor erythroid 2-related factor 2 | 86.45% | 96.00% |
| CHEMBL2095164 | P49354 | Geranylgeranyl transferase type I | 86.26% | 92.80% |
| CHEMBL5845 | P23415 | Glycine receptor subunit alpha-1 | 86.24% | 90.71% |
| CHEMBL321 | P14780 | Matrix metalloproteinase 9 | 86.19% | 92.12% |
| CHEMBL344 | Q99705 | Melanin-concentrating hormone receptor 1 | 85.75% | 92.50% |
| CHEMBL3430907 | Q96GD4 | Aurora kinase B/Inner centromere protein | 85.60% | 97.50% |
| CHEMBL3060 | Q9Y345 | Glycine transporter 2 | 85.27% | 99.17% |
| CHEMBL4660 | P28907 | Lymphocyte differentiation antigen CD38 | 84.87% | 95.27% |
| CHEMBL2955 | O95136 | Sphingosine 1-phosphate receptor Edg-5 | 84.77% | 92.86% |
| CHEMBL3238 | P23786 | Carnitine palmitoyltransferase 2 | 84.54% | 94.05% |
| CHEMBL3392948 | Q9NP59 | Solute carrier family 40 member 1 | 84.44% | 95.00% |
| CHEMBL1744525 | P43490 | Nicotinamide phosphoribosyltransferase | 84.39% | 96.25% |
| CHEMBL1907605 | P24864 | Cyclin-dependent kinase 2/cyclin E1 | 84.35% | 92.88% |
| CHEMBL249 | P25103 | Neurokinin 1 receptor | 83.97% | 99.17% |
| CHEMBL1075317 | P61964 | WD repeat-containing protein 5 | 83.90% | 96.33% |
| CHEMBL4361 | Q07820 | Induced myeloid leukemia cell differentiation protein Mcl-1 | 83.88% | 95.52% |
| CHEMBL3476 | O15111 | Inhibitor of nuclear factor kappa B kinase alpha subunit | 83.84% | 95.83% |
| CHEMBL4246 | P42680 | Tyrosine-protein kinase TEC | 83.39% | 82.05% |
| CHEMBL4657 | Q6V1X1 | Dipeptidyl peptidase VIII | 83.14% | 97.21% |
| CHEMBL5701 | Q9H2K8 | Serine/threonine-protein kinase TAO3 | 82.91% | 96.67% |
| CHEMBL3145 | P42338 | PI3-kinase p110-beta subunit | 82.68% | 98.75% |
| CHEMBL3776 | Q14790 | Caspase-8 | 82.47% | 97.06% |
| CHEMBL2069156 | Q14145 | Kelch-like ECH-associated protein 1 | 82.47% | 82.38% |
| CHEMBL5608 | Q16288 | NT-3 growth factor receptor | 82.33% | 95.89% |
| CHEMBL2140 | P48775 | Tryptophan 2,3-dioxygenase | 82.01% | 98.46% |
| CHEMBL5261 | Q7L7X3 | Serine/threonine-protein kinase TAO1 | 81.88% | 89.33% |
| CHEMBL5028 | O14672 | ADAM10 | 81.63% | 97.50% |
| CHEMBL4187 | Q99250 | Sodium channel protein type II alpha subunit | 81.10% | 95.50% |
| CHEMBL2007625 | O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | 80.57% | 99.00% |
| CHEMBL5043 | Q6P179 | Endoplasmic reticulum aminopeptidase 2 | 80.25% | 91.81% |
| CHEMBL1907602 | P06493 | Cyclin-dependent kinase 1/cyclin B1 | 80.14% | 91.24% |
Below are displayed all the plants proven (via scientific papers) to contain this
compound!
To see more specific details click the taxa you are interested in.
To see more specific details click the taxa you are interested in.
| There are no matching plants. |
| PubChem | 139587566 |
| LOTUS | LTS0273185 |
| wikiData | Q77569320 |